» Articles » PMID: 36684486

A Study to Evaluate the Knowledge, Vaccination Status and Acceptance of Adult Vaccinations Against Respiratory Infections in Patients with Type 2 Diabetes in South India

Overview
Date 2023 Jan 23
PMID 36684486
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Respiratory infections like influenza and pneumococcus increase mortality, morbidity, hospitalisation risks and healthcare costs in people with type 2 diabetes which can be prevented by vaccinations. However, there is not much data regarding how many people with type 2 diabetes in India receive pneumococcal and influenza vaccinations.

Methods: This is a cross-sectional study conducted between March 2022 to May 2022 at a tertiary care centre in South India. Patients were interviewed through face to face questionnaire regarding awareness, knowledge of influenza and pneumococcal infections, availability and need of vaccines, vaccination status and the possible reasons for not receiving vaccines.

Results: A total of 388 patients were recruited in the study. Knowledge about influenza and pneumococcal infections were present only in 4.8% and 4.1% respectively. And 98.7% of patients had no awareness about the availability and need for vaccines. Only 0.5% and 0.7% of patients received influenza and pneumococcal vaccinations respectively. After counselling and spreading awareness, 76.2% of patients said that they would receive vaccination in the next visit. Also, 23.19% of the patients refused to take any vaccinations even after counselling. And 23.7% of patients feared complications after vaccinations.

Conclusion: Pneumococcal and Influenza vaccination uptake rates are extremely low in people with type 2 diabetes in India. Urgent measures are required to increase the awareness in patients and healthcare workers about the availability, need for vaccinations and effectiveness of vaccines which would lead to improvement in vaccination rates.

Citing Articles

Diabetes mortality burden attributable to influenza in China: A population-based time-series analysis.

Tong S, Yin P, Li J, Zhao Z, Zhou Y, Zhou M Heliyon. 2025; 11(1):e41497.

PMID: 39850409 PMC: 11755021. DOI: 10.1016/j.heliyon.2024.e41497.

References
1.
Lu P, Hung M, Srivastav A, Grohskopf L, Kobayashi M, Harris A . Surveillance of Vaccination Coverage Among Adult Populations -United States, 2018. MMWR Surveill Summ. 2021; 70(3):1-26. PMC: 8162796. DOI: 10.15585/mmwr.ss7003a1. View

2.
Zamorano-Leon J, Jimenez-Garcia R, Lopez-de-Andres A, de-Miguel-Diez J, Carabantes-Alarcon D, Albaladejo-Vicente R . Low Levels of Influenza Vaccine Uptake among the Diabetic Population in Spain: A Time Trend Study from 2011 to 2020. J Clin Med. 2022; 11(1). PMC: 8745480. DOI: 10.3390/jcm11010068. View

3.
Kroneman M, van Essen G, Paget W . Influenza vaccination coverage and reasons to refrain among high-risk persons in four European countries. Vaccine. 2005; 24(5):622-8. DOI: 10.1016/j.vaccine.2005.08.040. View

4.
El Khoury G, Salameh P . Influenza Vaccination: A Cross-Sectional Survey of Knowledge, Attitude and Practices among the Lebanese Adult Population. Int J Environ Res Public Health. 2015; 12(12):15486-97. PMC: 4690936. DOI: 10.3390/ijerph121215000. View

5.
Almusalam Y, Ghorab M, Alanezi S . Prevalence of influenza and pneumococcal vaccine uptake in Saudi type 2 diabetic individuals. J Family Med Prim Care. 2019; 8(6):2112-2119. PMC: 6618205. DOI: 10.4103/jfmpc.jfmpc_265_19. View